United Kingdom

People: Bioanalytical Systems Inc (BASI.OQ)

BASI.OQ on NASDAQ Stock Exchange Capital Market

23 Aug 2019
Change (% chg)

$-0.08 (-2.88%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Oakley, Daniel 

Mr. Daniel Thomas Oakley is Chief Operating Officer of the Company. Mr. Oakley previously served as Chief Executive Officer of Seventh Wave Laboratories, LLC, a subsidiary of the Company. Mr. Oakley also served in that role from January 2018 through the Company’s acquisition of Seventh Wave Laboratories’ consulting-based contract research laboratory operations in July of 2018. From 2015 to 2017, Mr. Oakley held the position of Chief Executive Officer of DTO Associates, LLC, a private consulting company which advised companies on strategic concerns. Prior to his tenure at DTO Associates, LLC, Mr. Oakley was employed as President and Chief Operating Officer of MPI Research, Inc., a non-clinical contract research organization (now a subsidiary of Charles River Labs). There are no arrangements or understandings between Mr. Oakley and any other persons pursuant to which he was elected as an officer and Mr. Oakley has no family relationships with any other director or executive officer of the Company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --